252 related articles for article (PubMed ID: 33827485)
1. Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Yu Y; Xie Z; Zhao M; Lian X
BMC Cancer; 2021 Apr; 21(1):368. PubMed ID: 33827485
[TBL] [Abstract][Full Text] [Related]
2. Associations of
Shen X; Zhao Y; Chen X; Sun H; Liu M; Zhang W; Jiang F; Li P
Future Oncol; 2019 Jun; 15(16):1873-1894. PubMed ID: 30920860
[No Abstract] [Full Text] [Related]
3. Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population.
Huang Q; Zhou Y; Wang B; Zhao Y; Zhang F; Ding B
BMC Med Genomics; 2022 Jul; 15(1):146. PubMed ID: 35778737
[TBL] [Abstract][Full Text] [Related]
4. Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer.
Mosele F; Stefanovska B; Lusque A; Tran Dien A; Garberis I; Droin N; Le Tourneau C; Sablin MP; Lacroix L; Enrico D; Miran I; Jovelet C; Bièche I; Soria JC; Bertucci F; Bonnefoi H; Campone M; Dalenc F; Bachelot T; Jacquet A; Jimenez M; André F
Ann Oncol; 2020 Mar; 31(3):377-386. PubMed ID: 32067679
[TBL] [Abstract][Full Text] [Related]
5. Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer.
McCarthy AM; Kumar NP; He W; Regan S; Welch M; Moy B; Iafrate AJ; Chan AT; Bardia A; Armstrong K
BMC Cancer; 2020 Apr; 20(1):347. PubMed ID: 32326897
[TBL] [Abstract][Full Text] [Related]
6. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma.
Pei W; Jiang M; Liu H; Song J; Hu J
Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890
[TBL] [Abstract][Full Text] [Related]
7. Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer.
Ito C; Nishizuka SS; Ishida K; Uesugi N; Sugai T; Tamura G; Koeda K; Sasaki A
J Surg Res; 2017 May; 212():195-204. PubMed ID: 28550907
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
Zhou Y; Simmons J; Jordan CD; Sonbol MB; Maihle N; Tang SC
Clin Breast Cancer; 2019 Oct; 19(5):354-362.e7. PubMed ID: 31262687
[TBL] [Abstract][Full Text] [Related]
9.
Tang Y; Li J; Xie N; Yang X; Liu L; Wu H; Tian C; He Y; Wang X; He Q; Hu ZY; Ouyang Q
Aging (Albany NY); 2020 Jan; 12(2):1577-1590. PubMed ID: 31980592
[TBL] [Abstract][Full Text] [Related]
10.
Li AJ; Li HG; Tang EJ; Wu W; Chen Y; Jiang HH; Lin MB; Yin L
World J Gastroenterol; 2018 Feb; 24(5):631-640. PubMed ID: 29434452
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis.
Mei ZB; Duan CY; Li CB; Cui L; Ogino S
Ann Oncol; 2016 Oct; 27(10):1836-48. PubMed ID: 27436848
[TBL] [Abstract][Full Text] [Related]
12. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract][Full Text] [Related]
13. Exon 9 Mutation of
Seo AN; Kang BW; Bae HI; Kwon OK; Park KB; Lee SS; Chung HY; Yu W; Jeon SW; Kang H; Kim JG
Anticancer Res; 2019 Apr; 39(4):2145-2154. PubMed ID: 30952761
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
15. Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer.
Chen X; Guo Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xu Y; Xie Y
J Cancer Res Clin Oncol; 2019 May; 145(5):1235-1242. PubMed ID: 30806788
[TBL] [Abstract][Full Text] [Related]
16. Correlation between
Hu S; Zhao X; Qian F; Jin C; Hou K
Comput Math Methods Med; 2021; 2021():1522250. PubMed ID: 34603481
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study.
Kojima K; Imai S; Samejima H; Fujiwara A; Tokunaga T; Yoon H; Okishio K
BMC Cancer; 2022 Oct; 22(1):1066. PubMed ID: 36243681
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review.
Harada K; Baba Y; Shigaki H; Ishimoto T; Miyake K; Kosumi K; Tokunaga R; Izumi D; Ohuchi M; Nakamura K; Kiyozumi Y; Kurashige J; Iwatsuki M; Miyamoto Y; Sakamoto Y; Yoshida N; Watanabe M; Baba H
BMC Cancer; 2016 Jul; 16():400. PubMed ID: 27388016
[TBL] [Abstract][Full Text] [Related]
19. Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer.
Tury S; Becette V; Assayag F; Vacher S; Benoist C; Kamal M; Marangoni E; Bièche I; Lerebours F; Callens C
Oncotarget; 2016 Dec; 7(51):85124-85141. PubMed ID: 27835884
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Bioinformatic Analysis of NOTCH Pathway Involvement in Stomach Adenocarcinoma.
Xue D; Li D; Dou C; Li J
Dis Markers; 2021; 2021():4739868. PubMed ID: 34925644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]